Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
A Phase III Trial Comparing High Versus Standard Dose of Prophylactic Cranial Irradiation (PCI) in Limited Small Cell Lung Cancer Complete Responders
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
A PHASE3 clinical study on Lung Cancer, this trial is completed. The trial is conducted by European Organisation for Research and Treatment of Cancer - EORTC and has accumulated 6 data snapshots since 1999. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Sep 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Organisation for Research and Treatment of Cancer - EORTC
- Gustave Roussy, Cancer Campus, Grand Paris
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alès, France, Amiens, France, Amsterdam, Netherlands, Angers, France, Antwerp, Belgium, Argenteuil, France, Arnhem, Netherlands, Athens, Greece, Beauvais, France, Belgrade, Serbia and 80 more location s